270 related articles for article (PubMed ID: 18230060)
1. Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention.
Zhu W; Cheng KK; Vanhoutte PM; Lam KS; Xu A
Clin Sci (Lond); 2008 Mar; 114(5):361-74. PubMed ID: 18230060
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
4. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
5. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.
Kadowaki T; Yamauchi T; Kubota N
FEBS Lett; 2008 Jan; 582(1):74-80. PubMed ID: 18054335
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin: an update.
Guerre-Millo M
Diabetes Metab; 2008 Feb; 34(1):12-8. PubMed ID: 18069030
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and hypertension.
Ohashi K; Ouchi N; Matsuzawa Y
Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707
[TBL] [Abstract][Full Text] [Related]
8. Vascular actions of adipokines molecular mechanisms and therapeutic implications.
Xu A; Wang Y; Lam KS; Vanhoutte PM
Adv Pharmacol; 2010; 60():229-55. PubMed ID: 21081220
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
10. The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells.
Shin JH; Kim JH; Lee WY; Shim JY
Yonsei Med J; 2008 Oct; 49(5):804-10. PubMed ID: 18972601
[TBL] [Abstract][Full Text] [Related]
11. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies.
Han SH; Sakuma I; Shin EK; Koh KK
Prog Cardiovasc Dis; 2009; 52(2):126-40. PubMed ID: 19732605
[TBL] [Abstract][Full Text] [Related]
12. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin: from obesity to cardiovascular disease.
Antoniades C; Antonopoulos AS; Tousoulis D; Stefanadis C
Obes Rev; 2009 May; 10(3):269-79. PubMed ID: 19389061
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells.
Zhang P; Wang Y; Fan Y; Tang Z; Wang N
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):67-74. PubMed ID: 18988888
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of coronary dysfunction in obesity and insulin resistance.
Knudson JD; Dincer UD; Bratz IN; Sturek M; Dick GM; Tune JD
Microcirculation; 2007; 14(4-5):317-38. PubMed ID: 17613805
[TBL] [Abstract][Full Text] [Related]
16. Migraine as a systemic vasculopathy.
Tietjen GE
Cephalalgia; 2009 Sep; 29(9):987-96. PubMed ID: 19689607
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
Förstermann U
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
J Cardiovasc Pharmacol; 2008 Feb; 51(2):178-87. PubMed ID: 18287886
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin as a potential biomarker of vascular disease.
Ebrahimi-Mamaeghani M; Mohammadi S; Arefhosseini SR; Fallah P; Bazi Z
Vasc Health Risk Manag; 2015; 11():55-70. PubMed ID: 25653535
[TBL] [Abstract][Full Text] [Related]
20. Endothelin--role in vascular disease.
Abraham D; Dashwood M
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v23-4. PubMed ID: 18784133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
